Literature DB >> 11967333

Sites and determinants of early cleavages in the proteolytic processing pathway of reovirus surface protein sigma3.

Judit Jané-Valbuena1, Laura A Breun, Leslie A Schiff, Max L Nibert.   

Abstract

Entry of mammalian reovirus virions into target cells requires proteolytic processing of surface protein sigma3. In the virion, sigma3 mostly covers the membrane-penetration protein mu1, appearing to keep it in an inactive form and to prevent it from interacting with the cellular membrane until the proper time in infection. The molecular mechanism by which sigma3 maintains mu1 in this inactive state and the structural changes that accompany sigma3 processing and mu1 activation, however, are not well understood. In this study we characterized the early steps in sigma3 processing and determined their effects on mu1 function and particle infectivity. We identified two regions of high protease sensitivity, "hypersensitive" regions located at residues 208 to 214 and 238 to 244, within which all proteases tested selectively cleaved sigma3 as an early step in processing. Further processing of sigma3 was required for infection, consistent with the fact that the fragments resulting from these early cleavages remained bound to the particles. Reovirus type 1 Lang (T1L), type 3 Dearing (T3D), and T1L x T3D reassortant virions differed in the sites of early sigma3 cleavage, with T1L sigma3 being cleaved mainly at residues 238 to 244 and T3D sigma3 being cleaved mainly at residues 208 to 214. These virions also differed in the rates at which the early cleavages occurred, with cleavage of T1L sigma3 occurring faster than cleavage of T3D sigma3. Analyses using chimeric and site-directed mutants of recombinant sigma3 identified carboxy-proximal residues 344, 347, and 353 as the primary determinants of these strain differences. The spatial relationships between these more carboxy-proximal residues and the hypersensitive regions were discerned from the sigma3 crystal structure. The results indicate that proteolytic processing of sigma3 during reovirus disassembly is a multistep pathway with a number of molecular determinants.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11967333      PMCID: PMC136125          DOI: 10.1128/jvi.76.10.5184-5197.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Activation of influenza A viruses by trypsin treatment.

Authors:  H D Klenk; R Rott; M Orlich; J Blödorn
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

2.  Intraluminal proteolytic activation plays an important role in replication of type 1 reovirus in the intestines of neonatal mice.

Authors:  D M Bass; D Bodkin; R Dambrauskas; J S Trier; B N Fields; J L Wolf
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  Protease cleavage of reovirus capsid protein mu1/mu1C is blocked by alkyl sulfate detergents, yielding a new type of infectious subvirion particle.

Authors:  K Chandran; M L Nibert
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

4.  Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles.

Authors:  D B Furlong; M L Nibert; B N Fields
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

5.  Trypsin enhancement of rotavirus infectivity: mechanism of enhancement.

Authors:  S M Clark; J R Roth; M L Clark; B B Barnett; R S Spendlove
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

Review 6.  The structure and function of the hemagglutinin membrane glycoprotein of influenza virus.

Authors:  D C Wiley; J J Skehel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

7.  Early steps in reovirus infection are associated with dramatic changes in supramolecular structure and protein conformation: analysis of virions and subviral particles by cryoelectron microscopy and image reconstruction.

Authors:  K A Dryden; G Wang; M Yeager; M L Nibert; K M Coombs; D B Furlong; B N Fields; T S Baker
Journal:  J Cell Biol       Date:  1993-09       Impact factor: 10.539

Review 8.  Cathepsin B, Cathepsin H, and cathepsin L.

Authors:  A J Barrett; H Kirschke
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

9.  Proteolytic digestion of reovirus in the intestinal lumens of neonatal mice.

Authors:  D K Bodkin; M L Nibert; B N Fields
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

10.  A carboxy-terminal fragment of protein mu 1/mu 1C is present in infectious subvirion particles of mammalian reoviruses and is proposed to have a role in penetration.

Authors:  M L Nibert; B N Fields
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

View more
  25 in total

1.  Identification of a small-molecule entry inhibitor for filoviruses.

Authors:  Arnab Basu; Bing Li; Debra M Mills; Rekha G Panchal; Steven C Cardinale; Michelle M Butler; Norton P Peet; Helena Majgier-Baranowska; John D Williams; Ishan Patel; Donald T Moir; Sina Bavari; Ranjit Ray; Michael R Farzan; Lijun Rong; Terry L Bowlin
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  A capsid protein of nonenveloped Bluetongue virus exhibits membrane fusion activity.

Authors:  Mario Forzan; Christoph Wirblich; Polly Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

3.  A single mutation in the carboxy terminus of reovirus outer-capsid protein sigma 3 confers enhanced kinetics of sigma 3 proteolysis, resistance to inhibitors of viral disassembly, and alterations in sigma 3 structure.

Authors:  Gregory J Wilson; Emma L Nason; Charles S Hardy; Daniel H Ebert; J Denise Wetzel; B V Venkataram Prasad; Terence S Dermody
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Putative autocleavage of outer capsid protein micro1, allowing release of myristoylated peptide micro1N during particle uncoating, is critical for cell entry by reovirus.

Authors:  Amy L Odegard; Kartik Chandran; Xing Zhang; John S L Parker; Timothy S Baker; Max L Nibert
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

5.  Cell entry-associated conformational changes in reovirus particles are controlled by host protease activity.

Authors:  Jillann A Madren; Payel Sarkar; Pranav Danthi
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

6.  Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein.

Authors:  Kathryn Schornberg; Shutoku Matsuyama; Kirsten Kabsch; Sue Delos; Amy Bouton; Judith White
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Reovirus variants selected for resistance to ammonium chloride have mutations in viral outer-capsid protein sigma3.

Authors:  Kimberly M Clark; J Denise Wetzel; Yingqi Gu; Daniel H Ebert; Stephanie A McAbee; Emily K Stoneman; Geoffrey S Baer; Yuwei Zhu; Gregory J Wilson; B V V Prasad; Terence S Dermody
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

8.  Polymorphisms in the Most Oncolytic Reovirus Strain Confer Enhanced Cell Attachment, Transcription, and Single-Step Replication Kinetics.

Authors:  Adil Mohamed; James R Smiley; Maya Shmulevitz
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

9.  Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry.

Authors:  Maria V Yermolina; Jizhen Wang; Michael Caffrey; Lijun L Rong; Duncan J Wardrop
Journal:  J Med Chem       Date:  2011-01-04       Impact factor: 7.446

10.  Single Amino Acid Differences between Closely Related Reovirus T3D Lab Strains Alter Oncolytic Potency In Vitro and In Vivo.

Authors:  Adil Mohamed; Derek R Clements; Shashi A Gujar; Patrick W Lee; James R Smiley; Maya Shmulevitz
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.